<産業資料/調査レポートの題名> 2022年4月19日

神経科学用抗体及びアッセイの世界市場2020-2024


◆英文タイトル:Global Neuroscience Antibodies and Assays Market 2020-2024

01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
1. 2.1 Preface
2. 2.2 Currency conversion rates for US$
03: MARKET LANDSCAPE
3. Market ecosystem
4. Market characteristics
5. Market segmentation analysis
04: MARKET SIZING
6. Market definition
7. Market sizing 2019
8. Market outlook
9. Market size and forecast 2019-2024
05: FIVE FORCES ANALYSIS
10. Bargaining power of buyers
11. Bargaining power of suppliers
12. Threat of new entrants
13. Threat of substitutes
14. Threat of rivalry
15. Market condition
06: MARKET SEGMENTATION BY PRODUCT
16. Market segmentation by product
17. Comparison by product
18. Consumables – Market size and forecast 2019-2024
19. Instruments – Market size and forecast 2019-2024
20. Market opportunity by product
07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
21. Geographic segmentation
22. Geographic comparison
23. North America – Market size and forecast 2019-2024
24. Europe – Market size and forecast 2019-2024
25. Asia – Market size and forecast 2019-2024
26. ROW – Market size and forecast 2019-2024
27. Key leading countries
28. Market opportunity
09: DRIVERS AND CHALLENGES
29. Market drivers
30. Market challenges
10: MARKET TRENDS
31. High growth potential in emerging countries
32. Increasing focus on neurological disease research
33. Advances in neuroscience instruments
11: VENDOR LANDSCAPE
34. Overview
35. Landscape disruption
36. Competitive scenario
12: VENDOR ANALYSIS
37. Vendors covered
38. Vendor classification
39. Market positioning of vendors
40. Abcam Plc
41. Bio-Rad Laboratories Inc.
42. Cell Signaling Technology Inc.
43. F. Hoffmann-La Roche Ltd.
44. GenScript Biotech Corp.
45. Merck KGaA
46. Rockland Immunochemicals Inc.
47. Santa Cruz Biotechnology Inc.
48. Tecan Group Ltd.
49. Thermo Fisher Scientific Inc.
13: APPENDIX
50. Research methodology
51. List of abbreviations
52. Definition of market positioning of vendors
14: EXPLORE TECHNAVIO


Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Consumables – Year-over-year growth 2020-2024 (%)
Exhibit 22: Instruments – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Instruments – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Number of people aged 65 years and above in EU countries in 2005 and 2018 (in millions)
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
Exhibit 34: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abcam Plc – Vendor overview
Exhibit 47: Abcam Plc – Business segments
Exhibit 48: Abcam Plc – Organizational developments
Exhibit 49: Abcam Plc – Geographic focus
Exhibit 50: Abcam Plc – Key offerings
Exhibit 51: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 52: Bio-Rad Laboratories Inc. – Business segments
Exhibit 53: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 54: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 55: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 56: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 57: Cell Signaling Technology Inc. – Vendor overview
Exhibit 58: Cell Signaling Technology Inc. – Business segments
Exhibit 59: Cell Signaling Technology Inc. – Organizational developments
Exhibit 60: Cell Signaling Technology Inc. – Key offerings
Exhibit 61: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 62: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 63: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 64: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 65: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 66: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 67: GenScript Biotech Corp. – Vendor overview
Exhibit 68: GenScript Biotech Corp. – Business segments
Exhibit 69: GenScript Biotech Corp. – Organizational developments
Exhibit 70: GenScript Biotech Corp. – Geographic focus
Exhibit 71: GenScript Biotech Corp. – Segment focus
Exhibit 72: GenScript Biotech Corp. – Key offerings
Exhibit 73: Merck KGaA – Vendor overview
Exhibit 74: Merck KGaA – Business segments
Exhibit 75: Merck KGaA – Organizational developments
Exhibit 76: Merck KGaA – Geographic focus
Exhibit 77: Merck KGaA – Segment focus
Exhibit 78: Merck KGaA – Key offerings
Exhibit 79: Rockland Immunochemicals Inc. – Vendor overview
Exhibit 80: Rockland Immunochemicals Inc. – Business segments
Exhibit 81: Rockland Immunochemicals Inc. – Organizational developments
Exhibit 82: Rockland Immunochemicals Inc. – Key offerings
Exhibit 83: Santa Cruz Biotechnology Inc. – Vendor overview
Exhibit 84: Santa Cruz Biotechnology Inc. – Business segments
Exhibit 85: Santa Cruz Biotechnology Inc. – Key offerings
Exhibit 86: Tecan Group Ltd. – Vendor overview
Exhibit 87: Tecan Group Ltd. – Business segments
Exhibit 88: Tecan Group Ltd. – Organizational developments
Exhibit 89: Tecan Group Ltd. – Geographic focus
Exhibit 90: Tecan Group Ltd. – Segment focus
Exhibit 91: Tecan Group Ltd. – Key offerings
Exhibit 92: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 93: Thermo Fisher Scientific Inc. – Business segments
Exhibit 94: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 95: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 96: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 97: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 98: Validation techniques employed for market sizing
Exhibit 99: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark